Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Gilead Sciences Total Assets 2006-2021 | GILD

Gilead Sciences total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Gilead Sciences total assets for the quarter ending March 31, 2021 were $67.492B, a 12.97% increase year-over-year.
  • Gilead Sciences total assets for 2020 were $68.407B, a 11% increase from 2019.
  • Gilead Sciences total assets for 2019 were $61.627B, a 3.22% decline from 2018.
  • Gilead Sciences total assets for 2018 were $63.675B, a 9.4% decline from 2017.
  
Gilead Sciences Annual Total Assets
(Millions of US $)
2020 $68,407
2019 $61,627
2018 $63,675
2017 $70,283
2016 $56,977
2015 $51,716
2014 $34,664
2013 $22,579
2012 $21,240
2011 $17,303
2010 $11,593
2009 $9,699
2008 $6,937
2007 $5,835
2006 $4,086
2005 $3,766
Gilead Sciences Quarterly Total Assets
(Millions of US $)
2021-03-31 $67,492
2020-12-31 $68,407
2020-09-30 $60,878
2020-06-30 $55,934
2020-03-31 $59,741
2019-12-31 $61,627
2019-09-30 $59,146
2019-06-30 $63,210
2019-03-31 $62,837
2018-12-31 $63,675
2018-09-30 $64,305
2018-06-30 $65,355
2018-03-31 $65,381
2017-12-31 $70,283
2017-09-30 $64,662
2017-06-30 $60,263
2017-03-31 $57,701
2016-12-31 $56,977
2016-09-30 $56,609
2016-06-30 $49,980
2016-03-31 $47,765
2015-12-31 $51,716
2015-09-30 $50,637
2015-06-30 $39,167
2015-03-31 $38,321
2014-12-31 $34,664
2014-09-30 $28,844
2014-06-30 $31,206
2014-03-31 $28,078
2013-12-31 $22,579
2013-09-30 $22,468
2013-06-30 $22,624
2013-03-31 $22,212
2012-12-31 $21,240
2012-09-30 $20,964
2012-06-30 $20,502
2012-03-31 $19,950
2011-12-31 $17,303
2011-09-30 $12,640
2011-06-30 $12,694
2011-03-31 $12,987
2010-12-31 $11,593
2010-09-30 $11,456
2010-06-30 $10,497
2010-03-31 $10,696
2009-12-31 $9,699
2009-09-30 $8,937
2009-06-30 $8,387
2009-03-31 $7,520
2008-12-31 $6,937
2008-09-30 $6,974
2008-06-30 $6,517
2008-03-31 $5,879
2007-12-31 $5,835
2007-09-30 $5,318
2007-06-30 $4,826
2007-03-31 $4,615
2006-12-31 $4,086
2006-09-30 $5,299
2006-06-30 $5,180
2006-03-31 $4,037
2005-12-31 $3,766
2005-09-30 $2,919
2005-06-30 $2,688
2005-03-31 $2,369
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $84.093B $24.689B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $147.234B 10.21
Amgen (AMGN) United States $137.841B 14.87
CSL (CSLLY) Australia $103.116B 0.00
Moderna (MRNA) United States $88.882B 177.09
Illumina (ILMN) United States $67.991B 98.04
BioNTech SE (BNTX) Germany $57.117B 41.42
Regeneron Pharmaceuticals (REGN) United States $56.897B 16.29
Biogen (BIIB) United States $56.368B 12.90
Vertex Pharmaceuticals (VRTX) United States $48.892B 20.14
Alexion Pharmaceuticals (ALXN) United States $39.702B 15.08
BeiGene (BGNE) Cayman Islands $30.598B 0.00
Seagen (SGEN) United States $28.797B 49.74
Genmab (GMAB) Denmark $28.414B 33.31
Genmab (GNMSF) Denmark $25.850B 5.95
Exact Sciences (EXAS) United States $21.948B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.984B 26.83
Alnylam Pharmaceuticals (ALNY) United States $20.329B 0.00
Incyte (INCY) United States $18.713B 37.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.020B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $17.185B 90.36
ARGENX SE-ADR (ARGX) Netherlands $16.203B 0.00
Zai Lab (ZLAB) China $15.229B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.828B 135.23
Novavax (NVAX) United States $14.402B 0.00
Guardant Health (GH) United States $12.480B 0.00
CureVac (CVAC) Germany $10.860B 0.00
Repligen (RGEN) United States $10.824B 97.60
QIAGEN (QGEN) Netherlands $10.818B 19.21
CRISPR Therapeutics AG (CRSP) Switzerland $9.789B 0.00
Mirati Therapeutics (MRTX) United States $8.491B 0.00
Denali Therapeutics (DNLI) United States $8.379B 300.61
Fate Therapeutics (FATE) United States $7.656B 0.00
Acceleron Pharma (XLRN) United States $7.555B 0.00
Ascendis Pharma (ASND) Denmark $7.536B 0.00
Exelixis (EXEL) United States $7.155B 114.15
Ultragenyx Pharmaceutical (RARE) United States $6.395B 0.00
Sarepta Therapeutics (SRPT) United States $6.350B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.325B 0.00
Vir Biotechnology (VIR) United States $6.199B 0.00
Halozyme Therapeutics (HALO) United States $6.130B 33.63
AbCellera Biologics (ABCL) $5.979B 0.00
Twist Bioscience (TWST) United States $5.808B 0.00
I-Mab (IMAB) China $5.727B 0.00
Adaptive Biotechnologies (ADPT) United States $5.570B 0.00
Beam Therapeutics (BEAM) United States $5.381B 0.00
Intellia Therapeutics (NTLA) United States $5.378B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.325B 19.29
Legend Biotech (LEGN) United States $5.282B 0.00
NeoGenomics (NEO) United States $5.236B 888.00
Apellis Pharmaceuticals (APLS) United States $5.129B 0.00
Reata Pharmaceuticals (RETA) United States $5.091B 0.00
Blueprint Medicines (BPMC) United States $4.842B 14.74
Galapagos (GLPG) Belgium $4.700B 0.00
Certara (CERT) United States $4.155B 0.00
SpringWorks Therapeutics (SWTX) United States $4.090B 0.00
Arena Pharmaceuticals (ARNA) United States $4.059B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.985B 0.00
Alkermes (ALKS) Ireland $3.889B 0.00
Arvinas (ARVN) United States $3.642B 0.00
Intra-Cellular Therapies (ITCI) United States $3.614B 0.00
Berkeley Lights (BLI) United States $3.333B 0.00
Emergent Biosolutions (EBS) United States $3.154B 6.28
Dicerna Pharmaceuticals (DRNA) United States $2.861B 0.00
Insmed (INSM) United States $2.858B 0.00
Vericel (VCEL) United States $2.830B 763.25
BAVARIAN NORDIC (BVNRY) Denmark $2.814B 0.00
Amicus Therapeutics (FOLD) United States $2.631B 0.00
Sorrento Therapeutics (SRNE) United States $2.567B 0.00
MorphoSys AG (MOR) Germany $2.546B 0.00
Editas Medicine (EDIT) United States $2.470B 0.00
Heska (HSKA) United States $2.358B 1028.18
Instil Bio (TIL) United States $2.334B 0.00
Myriad Genetics (MYGN) United States $2.303B 0.00
ALX Oncology Holdings (ALXO) United States $2.288B 0.00
Global Blood Therapeutics (GBT) United States $2.243B 0.00
Revance Therapeutics (RVNC) United States $2.241B 0.00
Bluebird Bio (BLUE) United States $2.211B 0.00
Morphic Holding (MORF) United States $2.186B 0.00
Ligand Pharmaceuticals (LGND) United States $2.158B 36.10
Seres Therapeutics (MCRB) United States $2.139B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.086B 0.00
Seer (SEER) $2.065B 0.00
Kymera Therapeutics (KYMR) United States $2.003B 0.00
Prothena (PRTA) Ireland $2.002B 0.00
Bionano Genomics (BNGO) United States $1.988B 0.00
Myovant Sciences (MYOV) United Kingdom $1.977B 0.00
Atea Pharmaceuticals (AVIR) United States $1.940B 0.00
Protagonist Therapeutics (PTGX) United States $1.907B 0.00
Castle Biosciences (CSTL) United States $1.885B 0.00
Genetron Holdings (GTH) China $1.881B 0.00
Inovio Pharmaceuticals (INO) United States $1.822B 0.00
Amarin (AMRN) Ireland $1.796B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.773B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.719B 0.00
PHARMA MAR SA (PHMMF) Spain $1.705B 0.00
Alector (ALEC) United States $1.699B 0.00
Zymeworks (ZYME) Canada $1.673B 0.00
C4 Therapeutics (CCCC) United States $1.656B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
REGENXBIO (RGNX) United States $1.621B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.617B 0.00
Arcus Biosciences (RCUS) United States $1.615B 0.00
Cytokinetics (CYTK) United States $1.589B 0.00
NGM Biopharmaceuticals (NGM) United States $1.566B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.481B 0.00
Ocugen (OCGN) United States $1.469B 0.00
Avid Bioservices (CDMO) United States $1.447B 0.00
PureTech Health (PRTC) United States $1.421B 0.00
UniQure (QURE) Netherlands $1.405B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.373B 0.00
Codexis (CDXS) United States $1.350B 0.00
Precigen (PGEN) United States $1.300B 0.00
BioAtla (BCAB) United States $1.297B 0.00
MiMedx (MDXG) United States $1.286B 0.00
Zealand Pharma (ZEAL) Denmark $1.283B 0.00
Nurix Therapeutics (NRIX) United States $1.280B 0.00
Shattuck Labs (STTK) United States $1.236B 0.00
Northwest Biotherapeutics (NWBO) United States $1.236B 0.00
Keros Therapeutics (KROS) United States $1.225B 0.00
Repare Therapeutics (RPTX) Canada $1.203B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.190B 0.00
Agenus (AGEN) United States $1.152B 0.00
Coherus BioSciences (CHRS) United States $1.142B 0.00
Celldex Therapeutics (CLDX) United States $1.139B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
Mesoblast (MESO) Australia $1.114B 0.00
MannKind (MNKD) United States $1.111B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.091B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.044B 32.97
Scholar Rock Holding (SRRK) United States $1.032B 0.00
Dynavax Technologies (DVAX) United States $1.026B 0.00
Pliant Therapeutics (PLRX) United States $1.021B 0.00
VBI Vaccines (VBIV) United States $0.989B 0.00
Mersana Therapeutics (MRSN) United States $0.981B 0.00
Inhibrx (INBX) United States $0.948B 0.00
Avidity Biosciences (RNA) United States $0.943B 0.00
Epizyme (EPZM) United States $0.913B 0.00
Cel-Sci (CVM) United States $0.910B 0.00
Travere Therapeutics (TVTX) United States $0.901B 0.00
G1 THERAPEUTICS (GTHX) United States $0.899B 0.00
Nkarta (NKTX) United States $0.889B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.869B 0.00
RAPT THERAPTICS (RAPT) United States $0.869B 0.00
Prometheus Biosciences (RXDX) United States $0.860B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.858B 0.00
Sutro Biopharma (STRO) United States $0.850B 0.00
Merus (MRUS) Netherlands $0.834B 0.00
Affimed (AFMD) Germany $0.810B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.748B 0.00
Verastem (VSTM) United States $0.736B 0.00
SESEN BIO, INC (SESN) United States $0.717B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
IDEAYA Biosciences (IDYA) United States $0.707B 0.00
Pharming Group (PHAR) Netherlands $0.702B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.700B 0.00
Cara Therapeutics (CARA) United States $0.695B 60.39
Pharming Group (PHGUF) Netherlands $0.688B 18.33
Curis (CRIS) United States $0.688B 0.00
MeiraGTx Holdings (MGTX) United States $0.684B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.682B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.676B 0.00
AnaptysBio (ANAB) United States $0.675B 0.00
ALBIREO PHARMA (ALBO) United States $0.667B 0.00
Cellectis S.A (CLLS) France $0.664B 0.00
Kadmon Holdings (KDMN) United States $0.657B 0.00
Clene (CLNN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
DBV Technologies S.A (DBVT) France $0.635B 0.00
Clovis Oncology (CLVS) United States $0.615B 0.00
Anika Therapeutics (ANIK) United States $0.614B 0.00
Precision BioSciences (DTIL) United States $0.612B 0.00
Adagene (ADAG) China $0.610B 0.00
ChromaDex (CDXC) United States $0.603B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.600B 0.00
Bolt Biotherapeutics (BOLT) United States $0.581B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.572B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.535B 0.00
Compugen (CGEN) Israel $0.525B 0.00
Selecta Biosciences (SELB) United States $0.515B 0.00
Forte Biosciences (FBRX) United States $0.501B 0.00
Geron (GERN) United States $0.500B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.492B 0.00
XBiotech (XBIT) United States $0.486B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.478B 0.00
Starpharma Holdings (SPHRY) Australia $0.472B 0.00
Codiak BioSciences (CDAK) United States $0.468B 0.00
Gritstone Bio (GRTS) United States $0.457B 0.00
CytomX Therapeutics (CTMX) United States $0.451B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.444B 0.00
Athenex (ATNX) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.440B 0.00
Neoleukin Therapeutics (NLTX) United States $0.423B 0.00
Spero Therapeutics (SPRO) United States $0.422B 0.00
Amryt Pharma (AMYT) United Kingdom $0.420B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
ANI Pharmaceuticals (ANIP) United States $0.410B 11.32
Oncobiologics (OTLK) United States $0.406B 0.00
AquaBounty Technologies (AQB) United States $0.405B 0.00
Puma Biotechnology (PBYI) United States $0.396B 0.00
Angion Biomedica (ANGN) United States $0.387B 0.00
Cue Biopharma (CUE) United States $0.384B 0.00
Kala Pharmaceuticals (KALA) United States $0.369B 0.00
Theratechnologies (THTX) Canada $0.360B 0.00
SQZ Biotechnologies (SQZ) United States $0.359B 0.00
Adverum Biotechnologies (ADVM) United States $0.355B 0.00
BioDelivery Sciences (BDSI) United States $0.352B 14.28
XOMA (XOMA) United States $0.346B 161.63
UROGEN PHARMA (URGN) United States $0.344B 0.00
Fortress Biotech (FBIO) United States $0.343B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.337B 0.00
Opthea (OPT) Australia $0.334B 0.00
Cerecor (CERC) United States $0.334B 0.00
Frequency Therapeutics (FREQ) United States $0.330B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.329B 0.00
Cogent Biosciences (COGT) United States $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.322B 0.00
Athersys (ATHX) United States $0.320B 0.00
IBio (IBIO) United States $0.318B 0.00
Prima BioMed (IMMP) Australia $0.310B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
Trevena (TRVN) United States $0.308B 0.00
Adicet Bio (ACET) United States $0.300B 0.00
Arbutus Biopharma (ABUS) United States $0.299B 0.00
Fulcrum Therapeutics (FULC) United States $0.291B 0.00
CorMedix Inc (CRMD) United States $0.289B 0.00
OVID THERAPEUTC (OVID) United States $0.289B 2.84
Cardiff Oncology (CRDF) United States $0.288B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kaleido Biosciences (KLDO) $0.279B 0.00
Innate Pharma S.A (IPHA) France $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.271B 0.00
Bellus Health (BLU) Canada $0.262B 0.00
Clearside Biomedical (CLSD) United States $0.261B 0.00
Kamada (KMDA) Israel $0.258B 17.58
Talis Biomedical (TLIS) United States $0.258B 0.00
INmune Bio (INMB) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Chiasma (CHMA) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.232B 0.00
Seelos Therapeutics (SEEL) United States $0.225B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Synlogic (SYBX) United States $0.222B 0.00
NextCure (NXTC) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
VTv Therapeutics (VTVT) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.189B 0.00
Biofrontera AG (BFRA) Germany $0.186B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.183B 0.00
Galena Biopharma (SLS) United States $0.179B 0.00
OSMOTICA PHARM (OSMT) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.178B 0.00
Applied Genetic Technologies (AGTC) United States $0.177B 0.00
X4 Pharmaceuticals (XFOR) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
ObsEva SA (OBSV) Switzerland $0.169B 0.00
PHASEBIO PHARMA (PHAS) United States $0.166B 0.00
Abeona Therapeutics (ABEO) United States $0.163B 0.00
VolitionRX (VNRX) United States $0.161B 0.00
Voyager Therapeutics (VYGR) United States $0.160B 4.11
Antibe Therapeutics (ATBPF) Canada $0.158B 0.00
Cyclerion Therapeutics (CYCN) United States $0.150B 0.00
Enzo Biochem (ENZ) United States $0.146B 43.00
Longeveron (LGVN) United States $0.141B 0.00
Aytu BioPharma (AYTU) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Eyenovia (EYEN) United States $0.138B 0.00
Liquidia Technologies (LQDA) United States $0.137B 0.00
Exicure (XCUR) United States $0.136B 0.00
Beyond Air (XAIR) United States $0.135B 0.00
DiaMedica Therapeutics (DMAC) United States $0.133B 0.00
ABVC BioPharma (ABVC) United States $0.133B 0.00
Catalyst Biosciences (CBIO) United States $0.133B 0.00
Erytech Pharma SA (ERYP) France $0.132B 0.00
LogicBio Therapeutics (LOGC) United States $0.130B 0.00
Cocrystal Pharma (COCP) United States $0.128B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.127B 0.00
Novogen (KZIA) Australia $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.122B 0.00
Palatin Technologies (PTN) United States $0.122B 0.00
Evofem Biosciences (EVFM) United States $0.119B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.117B 0.00
Yumanity Therapeutics (YMTX) United States $0.115B 0.00
Orgenesis (ORGS) United States $0.113B 231.50
Vyant Bio (VYNT) United States $0.110B 0.00
Celsion (CLSN) United States $0.108B 0.00
Vascular Biogenics (VBLT) Israel $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.107B 0.00
Entera Bio (ENTX) Israel $0.106B 0.00
AEterna Zentaris (AEZS) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.106B 0.00
Aptevo Therapeutics (APVO) United States $0.105B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
TRACON Pharmaceuticals (TCON) United States $0.099B 0.00
Zosano Pharma (ZSAN) United States $0.098B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
Lumos Pharma (LUMO) United States $0.091B 0.00
Evogene (EVGN) Israel $0.088B 0.00
AIkido Pharma (AIKI) United States $0.086B 0.00
Protalix BioTherapeutics (PLX) Israel $0.085B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.085B 0.00
BioCardia (BCDA) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Purple Biotech (PPBT) Israel $0.080B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
Celyad SA (CYAD) Belgium $0.076B 0.00
Cleveland BioLabs (CBLI) United States $0.076B 0.00
ARIDIS PHARMACT (ARDS) United States $0.075B 0.00
ATyr Pharma (LIFE) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
Viridian Therapeutics (VRDN) United States $0.068B 0.00
Advaxis (ADXS) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Genetic Technologies (GENE) Australia $0.061B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.058B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Windtree Therapeutics (WINT) United States $0.056B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.053B 0.00
AnPac Bio-Medical Science (ANPC) China $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.11
Soligenix (SNGX) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Timber Pharmaceuticals (TMBR) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Vallon Pharmaceuticals (VLON) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
GeoVax Labs (GOVX) United States $0.032B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
ThermoGenesis Holdings (THMO) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ZIVO Bioscience (ZIVO) United States $0.023B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00